Dog Vaccine Market Size

Dog Vaccine Market Size - By Vaccine Type (Live Attenuated, Inactivated, Recombinant), Disease Type (Canine Distemper, CIRDC, Leptospirosis, Parvovirus, Rabies), Route of Administration (Injectable, Intranasal, Oral), End-use & Forecast, 2024 – 2032

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Dog Vaccine Market Size

Estimated to increase at 5.8% CAGR from 2024 to 2032, the USD 1.8 billion dog vaccination market size is currently Growing awareness of pet health together with rising frequency of canine diseases including rabies, parvovirus, and distemper and other disorders which underline the need of vaccinations drives the rise of this market. Furthermore projected to be major drivers of the vaccine market are millennials' growing ownership and their focus on canine preventative healthcare.

To get key market trends

  Download Free Sample

Millennials accounted for the highest proportion of pet ownership at 33% according to the National Pet Owners Survey taken by the American Pet Products Association, Inc. in 2023–2024. Comparably, a May 2023 Women's Health (Hearst UK) article revealed a poll showing 63% of millennials are spending more on their dogs than on themselves.

Dog Vaccine Market Report Attributes
Report Attribute Details
Base Year 2023
Dog Vaccine Market Size in 2023 USD 1.8 Billion
Forecast Period 2024 – 2032
Forecast Period 2024 – 2032 CAGR 5.8%
2024 – 2032 Value Projection USD 2.9 Billion
Historical Data for 2021 – 2023
No. of Pages 160
Tables, Charts & Figures 269
Segments covered Vaccine Type, Disease Type, Route of Administration, End-use, and Region
Growth Drivers
  • Adverse effects and the hesitancy for the vaccination
  • Stringent regulatory requirements
Pitfalls & Challenges
  • Adverse effects and the hesitancy for the vaccination
  • Stringent regulatory requirements

What are the growth opportunities in this market?

 Download Free Sample

By inducing their immune system to identify and fight against particular infections, dog vaccinations are a biological preparation meant to help dogs avoid different diseases. Antigens found in vaccines resemble disease-causing organisms, therefore inducing an immune reaction without actually producing the disease. This lowers the chance of major disease or death by arming the dog's immune system to identify and react to future infections.

Dog Vaccine Market Trends

Government initiatives for animal healthcare such as subsidized vaccination programs and public awareness campaigns to address the infection burden propel the need for animal vaccines. These initiatives encouraged higher vaccination rates and fostered a healthier pet population.

  • For example, substantial mass dog vaccination programs, post-exposure prophylactic measures for bite victims, and national awareness campaigns result from a combined effort by the Ministries of Health, Fisheries & Livestock, Local Government, Rural Development & Cooperative, and Education. These inter-sectoral projects seek to meet the demand for preventative vaccinations in response to dog illness incidence increasing. Dogs throughout all 64 districts received over 2.25 million doses of the rabies vaccination, covering 81.57% by June 2022. Therefore, the increasing government backing for mass vaccination drove the need for vaccines, so increasing the growth in the dog vaccination market.

Moreover, the growing trend of pet humanization, favorable pet insurance policies, advancements in animal health treatment, accelerated research activities, strategic expansions by key players, and increasing vaccine approvals are further driving market demand.

Dog Vaccine Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on the vaccine type, the market is categorized into live attenuated, inactivated, recombinant, and other vaccine types. The live attenuated segment is set to lead the market, accounting for the largest revenue of USD 800.4 million, anticipating its dominance throughout the forecast period with a significant growth rate.

  • Weak versions of the pathogen used in live attenuated vaccines induce a strong immune response without producing the disease. This makes durable and efficient defense against several canine diseases possible, so the recommended choice is this one.
  • Moreover, these vaccines are more practical for vets and pet owners as they sometimes call for less doses. Their potency is much enhanced by their capacity to generate humoral as well as cellular immunity. Consequently, they are rather popular and trustworthy in the veterinary community, which helps to explain their market domination. The market in dog vaccinations is expanding.

Learn more about the key segments shaping this market

 Download Free Sample

Based on disease type, the dog vaccine market is classified into canine distemper, canine infectious respiratory disease complex (CIRDC), canine parvovirus, canine leptospirosis, canine lyme disease, infectious canine hepatitis, canine rabies, and other disease types. The canine parvovirus segment holds the largest market share of 25.3% in 2023.

  • The great contagiousness of canine parvovirus and its devastating effect on canine health helped to explain its dominance. Over 330,000 puppies are thought to be affected by parvovirus yearly; if treated, as many as 91% of them die. Particularly harmful for puppies, this infection causes extreme stomach problems and dehydration. Thus, the great requirement for efficient immunization results from the high death rate and quick spread of parvovirus.
  • Furthermore, new vaccines along with awareness about parvovirus among owners would help the industry to thrive. To increase knowledge about the serious and often fatal puppy disease, Elanco Animal Health Incorporated, for example, conducted a thorough educational campaign marked as the first National Parvo Awareness Day. Elanco presents "Parvo is Poop," an interesting commercial effort that clarifies the virus's spread, symptoms, and creative treatment for canine parvovirus (parvo). This project sought to raise awareness in order to solve parvovirus-related issues and improve the general canine health worldwide.

Based on route of administration, the dog vaccine market is segmented into intranasal, injectable, and oral. The injectable segment is expected to exhibit CAGR of 5.7% during the analysis period.

  • Because injectable vaccines guarantee exact dosing and consistent administration, they rule the dog vaccination market. For their ability to produce consistent immunological responses, injectable immunizations are preferred by pet owners and veterinarians.
  • For instance, MSD Animal Health debuted Nobivac Respira, a single-dose injectable vaccination providing enhanced Bordetella bronchiseptica protection in March 2021. Thus, the trust and familiarity veterinarians have with injectable vaccines support their extensive usage and preference in preventing canine diseases, so enhancing the market growth.

Based on the end-use

the dog vaccine market is segmented into veterinary hospitals, veterinary clinics, and research institutes. The veterinary hospitals segment is projected to reach USD 1.3 billion by end of 2032.

  • Veterinary hospitals offer comprehensive medical services including vaccinations, making them a preferred choice for pet owners seeking preventive care for their dogs. Also, these facilities have well-trained staff, advanced equipment, and established trust with pet owners, leading to higher vaccination rates.
  • Moreover, veterinary hospitals often provide tailored vaccination schedules and recommendations based on individual pet needs, further solidifying their dominance in the market for dog vaccines.

Looking for region specific data?

 Download Free Sample

The U.S. dominated the North American dog vaccine market accounting for USD 683.4 million in 2023.

  • Pet dogs abound in the United States; millions of homes have at least one canine friend. For example, according to an August 2023 My Golden Retriever Puppies post, the U.S. alone hosts an estimated 89.7 million pet dogs, therefore dogs and cats are universally loved and valued as pets. This great incidence of pet ownership produced a big market for dog vaccinations.
  • Furthermore enabling broad access to vaccination services is the well-developed veterinary healthcare system of the United States, which comprises veterinary clinics, hospitals, and research institutes. Moreover, the presence of top companies and creative research in the United States helps to explain its supremacy; the nation often leads in developments in companion medicine and vaccination research. Such indicated element is supposed to drive country level market expansion.

Germany exhibited a high growth potential in the European dog vaccine market.

  • Germany plays a significant role in the European dog vaccine industry due to its extensive scientific research, innovation, and development in animal health. Germany's strong research infrastructure and regulatory environment support the development of new vaccines and ensure their safety and efficacy.
  • Further, the country's high pet ownership rate, particularly for dogs, drives demand for dog vaccines.

The Asia Pacific dog vaccine market is poised for rapid growth with a CAGR of 6.3% during the forecast period.

  • The Asia Pacific region offers substantial growth potential in the dog vaccine industry driven by increasing urbanization, higher disposable incomes, and changing lifestyles. As more households welcome dogs into their families, the demand for pet healthcare, including vaccinations, has surged.
  • Also, government initiatives promoting responsible pet ownership and public health awareness campaigns also play a role in driving vaccine uptake. For instance, in 2022, the Brihanmumbai Municipal Corporation (BMC) partnered with Mission Rabies to pursue a rabies-free status for Mumbai, India. A pilot program in September and October inoculated over 14,000 dogs, while a 2024 drive aligns with a national initiative to eliminate rabies in India by 2030, intending to vaccinate thousands more. This collaborative effort aimed to accelerate vaccination programs is expected to supplement the market expansion.

Dog Vaccine Market Share

Prominent companies providing a large range of vaccines aiming at different canine diseases define the dog vaccination market. These businesses have strong names and wide-ranging systems of distribution. Focusing on creative vaccine formulations and increasing their market presence, the young players are acquiring momentum. Companies fighting on product efficacy, safety, pricing, and market reach create intense competition. The dynamic character of the market guarantees continuous development as new competitors join the market and current firms invent to keep their competitive edge.

Dog Vaccine Market Companies

Some of the prominent players operating in the dog vaccine industry include

Dog Vaccine Industry News

  • In March 2024, Merck Animal Health, collaborating with Mission Rabies, is committed to aiding the ambitious global objective of the United Against Rabies Forum, aiming for zero human deaths from dog-mediated rabies by 2030. Their contribution includes donations of NOBIVAC rabies vaccines, extending over the next five years. These donations will fulfill the annual rabies vaccine needs of the non-profit organization. This partnership underscores the dedication of both entities to combatting rabies and saving lives globally.
  • In March 2024, Petia Vet Health, a subsidiary of the Zendal group, launched the Neoleish vaccine, the first vaccine for animal mammals based on recombinant DNA, to address canine leishmaniasis. Dedicated to pet health, Petia Vet Health will oversee the vaccine's marketing in Spain. This innovative vaccine launched marked a significant advancement in combating canine leishmaniasis and explored and opportunity in the animal healthcare sector.

The dog vaccine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Vaccine Type

  • Live attenuated
  • Inactivated
  • Recombinant
  • Other vaccine types

Market, By Disease Type

  • Canine distemper
  • Canine infectious respiratory disease complex (CIRDC)
  • Canine parvovirus
  • Canine leptospirosis
  • Canine lyme disease
  • Infectious canine hepatitis
  • Canine rabies
  • Other disease types

Market, By Route of Administration

  • Intranasal
  • Injectable
  • Oral

Market, By End-use

  • Veterinary hospitals
  • Veterinary clinics
  • Research institutes

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email